Supporting Caregivers in Transitioning Children to pDTG2

Overview

Evidence to Action (E2A) is a webinar series created by EGPAF to share novel approaches and best practices in global health programs.

In this edition of our E2A webinar, The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. Agency for International Development (USAID), Caris Foundation International, and the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will discuss practical ways that communities and caregivers can support children living with HIV in their transition to pediatric dolutegravir (pDTG). This webinar builds on the momentum around WHO’s guidance recommending dolutegravir as the preferred anchor ARV for people living with HIV and the recent availability of pDTG to treat children down to 4 weeks of age and who weigh at least 3 kilograms. This discussion will include a review of new science, to be published at the 2021 International AIDS Society Conference. OVC programs and community organizations supporting families with children who receive HIV treatment will share their experiences promoting demand creation, reinforcing treatment literacy, and offering ART adherence support to caregivers of children transitioning to a new ARV.